<DOC>
	<DOCNO>NCT00906048</DOCNO>
	<brief_summary>The primary objective : assess microbiological success combination levofloxacin rifampicin , administer 32 37 day , oral replacement therapy empirical antibiotic therapy maximum 5 10 day give intravenously , treatment OsteoArticular Prosthetic Infections ( OAPI ) , two-stage revision prosthesis . The secondary endpoint : - To assess rate clinical failure 12 month reimplantation prosthesis . - To assess joint mobility function score 12 month reimplantation prosthesis . - To assess safety combination levofloxacin rifampicin . - To investigate prognostic factor success end treatment 12 month reimplantation prosthesis .</brief_summary>
	<brief_title>LEVOS - Levofloxacin Rifampicin Therapy Treatment OsteoArticular Prothethic Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>Inclusion criterion : Osteoarticular prosthetic bacterial infection ( hip knee ) Documented microbiological infection due Staphylococcus aureus and/or coagulasenegative staphylococci , susceptible fluoroquinolones rifampicin : For Staphylococcus aureus , minimum 2 positive perioperative sample require . For coagulasenegative staphylococci , minimum 3 positive perioperative sample require . In event combination , minimum 2 positive perioperative sample Staphylococcus aureus minimum 3 positive perioperative sample coagulasenegative staphylococci . Twostage surgical management : first operative stage : removal prosthesis , large debridement , implantation spacer second operative stage : implantation new cement prosthesis ( If possible , without antibiotic recommend Sofcot ( 25 ) , otherwise contain gentamicin ) . Negative urine pregnancy test female childbearing age . A barrier contraception method throughout duration treatment 4 week follow discontinuation rifampicin female childbearing age . Exclusion criterion : Osteoarticular prosthetic infection one site . Osteoarticular prosthetic infection without bacteriological documentation . Infection due staphylococci susceptible fluoroquinolones rifampicin . Infection due staphylococci . Absence surgical management . More 2 surgical repeat due infection infect site . Renal impairment creatinine clearance &lt; 50 ml/min . Hepatic impairment . Hypersensitivity levofloxacin , product quinolone class , rifamycins excipients study product . A history tendinopathy associate fluoroquinolone . Glucose6phosphate dehydrogenase deficiency . History convulsion epilepsy predispose factor occurrence convulsion . Porphyria . Combination use protease inhibitor delavirdine nevirapine . Estrogenprogestin progestin contraceptive . Patient 65 year age receive corticosteroid . Breastfeeding female . Pregnant female female likely become pregnant . HIV infection . Inflammatory rheumatism . Treatment immunosuppressive agent , cardiovascular , neurological endocrine disease , medically significant disease ( cancer , etc . ) make conduct protocol interpretation result trial difficult . A history abuse medicinal product alcohol . A patient may receive treatment authorize protocol trial . Treatment another product undergo pharmaceutical development 4 week prior inclusion trial . Patient participate another trial . Patient allergic gentamicin , event implantation spacer cement gentamicin . Mental condition make patient incapable understanding nature , objectives possible consequence trial . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>